MedPath

EDP-239

Generic Name
EDP-239

Two-way Interaction Between Alisporivir and EDP239

Phase 1
Completed
Conditions
Hepatitis C Virus
Interventions
First Posted Date
2014-06-25
Last Posted Date
2015-01-09
Lead Sponsor
Enanta Pharmaceuticals, Inc
Target Recruit Count
42
Registration Number
NCT02173574
Locations
🇩🇪

Investigative Site, Berlin, Germany

Proof of Concept Study for Safety and Efficacy of EDP239 in Hepatitis C Subjects

Phase 1
Completed
Conditions
Hepatitis C
Interventions
Drug: Placebo
First Posted Date
2013-05-17
Last Posted Date
2016-01-29
Lead Sponsor
Enanta Pharmaceuticals, Inc
Target Recruit Count
28
Registration Number
NCT01856426
Locations
🇩🇪

Investigative Site, Hamburg, Germany

© Copyright 2025. All Rights Reserved by MedPath